Thrivent Financial for Lutherans Purchases 4,255 Shares of Masimo Corporation $MASI

Thrivent Financial for Lutherans increased its position in Masimo Corporation (NASDAQ:MASI) by 40.2% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 14,851 shares of the medical equipment provider’s stock after acquiring an additional 4,255 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Masimo were worth $2,191,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the business. Royal Bank of Canada increased its stake in shares of Masimo by 44.5% in the first quarter. Royal Bank of Canada now owns 43,884 shares of the medical equipment provider’s stock worth $7,311,000 after purchasing an additional 13,513 shares in the last quarter. AQR Capital Management LLC lifted its stake in shares of Masimo by 136.5% during the 1st quarter. AQR Capital Management LLC now owns 8,142 shares of the medical equipment provider’s stock valued at $1,305,000 after buying an additional 4,700 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Masimo by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock worth $1,894,000 after buying an additional 66 shares during the period. Dynamic Technology Lab Private Ltd purchased a new position in Masimo in the 1st quarter valued at approximately $220,000. Finally, Jones Financial Companies Lllp grew its stake in Masimo by 1,267.1% in the 1st quarter. Jones Financial Companies Lllp now owns 2,201 shares of the medical equipment provider’s stock valued at $367,000 after buying an additional 2,040 shares in the last quarter. 85.96% of the stock is owned by hedge funds and other institutional investors.

Masimo Stock Performance

NASDAQ:MASI opened at $134.10 on Wednesday. The business’s 50-day moving average price is $136.97 and its two-hundred day moving average price is $143.18. Masimo Corporation has a twelve month low of $125.94 and a twelve month high of $194.88. The stock has a market cap of $7.20 billion, a P/E ratio of -12.72, a PEG ratio of 1.37 and a beta of 1.26. The company has a quick ratio of 1.92, a current ratio of 2.84 and a debt-to-equity ratio of 0.69.

Analyst Upgrades and Downgrades

Several research firms have issued reports on MASI. Bank of America began coverage on Masimo in a research report on Monday, November 17th. They set a “neutral” rating and a $162.00 target price on the stock. BTIG Research boosted their price objective on Masimo from $198.00 to $200.00 and gave the company a “buy” rating in a research note on Thursday, December 4th. Zacks Research downgraded Masimo from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 24th. Needham & Company LLC reaffirmed a “hold” rating on shares of Masimo in a report on Monday, December 1st. Finally, Wells Fargo & Company reissued an “overweight” rating and issued a $190.00 price target on shares of Masimo in a report on Friday, December 5th. Four research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Masimo presently has a consensus rating of “Hold” and a consensus target price of $189.40.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.